Balance Sheet Data

Intellia Therapeutics, Inc. (NTLA)

$32.39

-1.14 (-3.40%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 314.06279.73597.371,086.051,261.961,076.831,321.421,621.581,989.912,441.91
Total Cash (%)
Account Receivables 7.554.622.132.033.776.728.2510.1312.4315.25
Account Receivables (%)
Inventories ---19.15-337.36-69.34-253.01-310.48-381-467.54-573.74
Inventories (%)
Accounts Payable 2.713.9410.469.655.159.6211.8014.4817.7721.81
Accounts Payable (%)
Capital Expenditure -6.36-6.79-3.59-12.76-58.39-24.75-30.37-37.27-45.73-56.12
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.